Growth factor 31 (IGF31)

This project focuses on a protein called insulin-like growth factor (IGF), which helps cancers to grow and spread.

Men with high levels of IGF in their blood are at increased risk of getting prostate cancer. The research team are testing the prostates of men who have had their prostates removed as treatment for prostate cancer, and measuring their blood IGF levels, to try to understand how high IGF increases prostate cancer risk.

The long-term goal is to work out how to stop the development of prostate cancer.

Pictured are Dr Val Macaulay and Dr Tamara Aleksic who are working on the project.